Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Glenmark Pharmaceuticals Limited
Press Release Dec 14 2021
Business
Dec 14 2021
5 min read

Press Release Dec 14 2021

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 14, 2021, titled "Glenmark's subsidiary, lchnos Sciences and Almirall enter into an exclusive LicensingAgreement for First-In-Class IL-lRAP Antagonist Monoclonal Antibody".

View Attachment